Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 14, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Closing of Public Offering of 9,372,500 Shares of Common Stock Including Full Exercise of Option to Purchase Additional Shares

SOUTH SAN FRANCISCO, Calif., Dec. 14, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the closing of its...
December 12, 2018 01:01 ET | Source: Fluidigm Corporation

Fluidigm Announces Pricing of Public Offering of 8,150,000 Shares of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced the pricing of an...
December 11, 2018 16:01 ET | Source: Fluidigm Corporation

Fluidigm Announces Commencement of Public Offering of Common Stock

SOUTH SAN FRANCISCO, Calif., Dec. 11, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, today announced that it intends to...
November 12, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm to Participate in the 30th Annual Piper Jaffray Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ: FLDM), a leader in mass cytometry and microfluidics technologies, announced today that the company’s...
November 09, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced that the Compensation Committee of its Board of Directors, which is comprised...
November 08, 2018 08:30 ET | Source: Fluidigm Corporation

Fluidigm Showcases Immuno-Oncology Innovations for Translational and Clinical Research at SITC 2018

A comprehensive suite of innovative immuno-oncology applications to improve the future of cancer care SOUTH SAN FRANCISCO, Calif., Nov. 08, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation...
November 07, 2018 16:11 ET | Source: Fluidigm Corporation

Fluidigm Recognized as a Company to Watch in 2019

Immuno-oncology innovator receives life science people’s choice award SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- BioInformatics Inc., the leading research and advisory firm...
November 01, 2018 16:05 ET | Source: Fluidigm Corporation

Fluidigm Announces Third Quarter 2018 Financial Results

Total revenue increases 17 percent to $29.0 million Mass cytometry revenue growth of 50 percent Instrument revenue growth of 32 percent SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018...
November 01, 2018 08:30 ET | Source: Fluidigm Corporation

Sirona Dx Introduces Imaging Mass Cytometry Services to Advance Biomarker Discovery and Therapeutic Development

Specialized CRO offers high-definition tissue imaging services for pharmaceutical and clinical research SOUTH SAN FRANCISCO, Calif. and PORTLAND, Ore., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sirona Dx,...
October 31, 2018 08:30 ET | Source: Fluidigm Corporation

Laura Clague Named to Fluidigm Board of Directors

Senior Financial Leader with Broad Corporate and Biotech Expertise SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment...